V. Mavichak

550 total citations
26 papers, 397 citations indexed

About

V. Mavichak is a scholar working on Epidemiology, Transplantation and Infectious Diseases. According to data from OpenAlex, V. Mavichak has authored 26 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 8 papers in Transplantation and 6 papers in Infectious Diseases. Recurrent topics in V. Mavichak's work include Renal Transplantation Outcomes and Treatments (7 papers), Magnesium in Health and Disease (6 papers) and Cytomegalovirus and herpesvirus research (6 papers). V. Mavichak is often cited by papers focused on Renal Transplantation Outcomes and Treatments (7 papers), Magnesium in Health and Disease (6 papers) and Cytomegalovirus and herpesvirus research (6 papers). V. Mavichak collaborates with scholars based in Thailand, Canada and United States. V. Mavichak's co-authors include S. Jirasiritham, John H. Dirks, Norman L.M. Wong, Roger A.L. Sutton, R. A. L. Sutton, V. Sumethkul, Gary A. Quamme, G E Wilkins, A. Halabe and Siriorn P. Watcharananan and has published in prestigious journals such as Scientific Reports, Kidney International and Annals of Oncology.

In The Last Decade

V. Mavichak

24 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Mavichak Thailand 11 90 84 84 80 73 26 397
Annick Massart Belgium 14 69 0.8× 16 0.2× 67 0.8× 49 0.6× 158 2.2× 34 490
D Dahmane France 6 93 1.0× 36 0.4× 20 0.2× 17 0.2× 78 1.1× 10 414
B. Klare Germany 12 45 0.5× 28 0.3× 38 0.5× 15 0.2× 104 1.4× 23 441
K. V. Dakshinamurty India 11 89 1.0× 31 0.4× 78 0.9× 29 0.4× 114 1.6× 28 303
Elen Almeida Romão Brazil 10 44 0.5× 53 0.6× 22 0.3× 16 0.2× 37 0.5× 38 325
Rosalía Valero Spain 12 87 1.0× 20 0.2× 35 0.4× 12 0.1× 158 2.2× 41 483
Philippe Eckart France 6 160 1.8× 48 0.6× 87 1.0× 36 0.5× 17 0.2× 8 290
Donald A. Leeber United States 8 47 0.5× 35 0.4× 41 0.5× 12 0.1× 100 1.4× 13 429
Magdalena Salcedo Spain 13 226 2.5× 43 0.5× 40 0.5× 22 0.3× 243 3.3× 43 508
Brian Gallay United States 11 68 0.8× 24 0.3× 24 0.3× 11 0.1× 275 3.8× 21 592

Countries citing papers authored by V. Mavichak

Since Specialization
Citations

This map shows the geographic impact of V. Mavichak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Mavichak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Mavichak more than expected).

Fields of papers citing papers by V. Mavichak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Mavichak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Mavichak. The network helps show where V. Mavichak may publish in the future.

Co-authorship network of co-authors of V. Mavichak

This figure shows the co-authorship network connecting the top 25 collaborators of V. Mavichak. A scholar is included among the top collaborators of V. Mavichak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Mavichak. V. Mavichak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mavichak, V., et al.. (2024). Report on post-transplantation cancer in southeast Asia from the Thai kidney transplantation cohort. Scientific Reports. 14(1). 20154–20154.
2.
Watcharananan, Siriorn P., Peera Jaru-Ampornpan, Anan Jongkaewwattana, et al.. (2022). Comparison of the immunogenicity of ChAdOx1 nCoV-19 vaccine against the wild-type and delta variants in kidney transplant recipients and healthy volunteers. American Journal of Transplantation. 22(5). 1459–1466. 9 indexed citations
3.
Watcharananan, Siriorn P., et al.. (2012). Prevalence of Pretransplant Infections among South East Asian Kidney Transplant Recipients. Transplantation. 94(10S). 548–548. 1 indexed citations
4.
Watcharananan, Siriorn P., Robin K. Avery, Atiporn Ingsathit, et al.. (2011). Adenovirus Disease after Kidney Transplantation: Course of Infection and Outcome in Relation to Blood Viral Load and Immune Recovery. American Journal of Transplantation. 11(6). 1308–1314. 46 indexed citations
5.
Watcharananan, Siriorn P., et al.. (2010). Adenovirus Infection After Kidney Transplantation in Thailand: Seasonal Distribution and Potential Route of Acquisition. Transplantation Proceedings. 42(10). 4091–4093. 6 indexed citations
6.
Watcharananan, Siriorn P., et al.. (2010). Influenza A/H1N1 2009 pneumonia in kidney transplant recipients: characteristics and outcomes following high-dose oseltamivir exposure. Transplant Infectious Disease. 12(2). 127–131. 22 indexed citations
7.
Jirasiritham, S., et al.. (2010). Treatment of Simultaneous Acute Antibody-Mediated Rejection and Acute Cellular Rejection With Alemtuzumab in Kidney Transplantation: A Case Report. Transplantation Proceedings. 42(3). 987–989. 8 indexed citations
8.
Ativitavas, Touch, et al.. (2008). Malignancies in Renal Transplant Patients: 15 Years Experience in Thailand. Transplantation Proceedings. 40(7). 2403–2404. 7 indexed citations
9.
Ekpanyaskul, Chatchai, et al.. (2008). Tuberculosis in Thai Renal Transplant Recipients: A 15-Year Experience. Transplantation Proceedings. 40(7). 2376–2379. 20 indexed citations
10.
Jirasiritham, S., V. Sumethkul, V. Mavichak, & K Na‐Bangchang. (2004). The pharmacokinetics of mycophenolate mofetil in Thai kidney transplant recipients. Transplantation Proceedings. 36(7). 2076–2078. 25 indexed citations
11.
Jirasiritham, S., V. Sumethkul, V. Mavichak, & Panuwat Lertsithichai. (2004). The role of anti–IL-2 receptor in high-risk kidney transplant patients. Transplantation Proceedings. 36(7). 2110–2112. 10 indexed citations
12.
Mavichak, V., et al.. (2003). Conversion of C-0 to C-2 monitoring of cyclosporine in stable kidney transplant patients. Transplantation Proceedings. 35(1). 236–237. 3 indexed citations
13.
Jirasiritham, S., et al.. (2000). The treatment of chronic rejection with mycophenolate mofetil versus azathioprine in kidney transplantation. Transplantation Proceedings. 32(7). 2040–2042. 2 indexed citations
14.
Sumethkul, V., et al.. (2000). Spouse donor kidney transplantation in Thailand. Transplantation Proceedings. 32(7). 1600–1601. 6 indexed citations
15.
Jirasiritham, S., et al.. (1998). Treatment of chronic rejection in renal transplantation by mycophenolate mofetil (MMF): a preliminary report of six-month experience. Transplantation Proceedings. 30(7). 3576–3577. 8 indexed citations
16.
Sumethkul, V., et al.. (1998). Use of microemulsion form cyclosporine immediately after kidney transplantation without intravenous cyclosporine. Transplantation Proceedings. 30(5). 1760–1761. 3 indexed citations
17.
Wong, Norman L.M., V. Mavichak, Alex B. Magil, Roger A.L. Sutton, & John H. Dirks. (1988). Sodium Thiosulfate Prevents Cisplatin-Induced Hypomagnesemia. ˜The œNephron journals/Nephron journals. 50(4). 308–314. 5 indexed citations
18.
Mavichak, V., et al.. (1988). Continuous peritoneal dialysis in acute renal failure from severe falciparum malaria.. PubMed. 29(3). 137–43. 22 indexed citations
19.
Magil, Alex B., V. Mavichak, Norman L.M. Wong, et al.. (1986). Long-Term Morphological and Biochemical Observations in Cisplatin-Induced Hypomagnesemia in Rats. ˜The œNephron journals/Nephron journals. 43(3). 223–230. 20 indexed citations
20.
Wong, Norman L.M., Roger A.L. Sutton, V. Mavichak, Gary A. Quamme, & John H. Dirks. (1985). Enhanced distal absorption of potassium by magnesium-deficient rats. Clinical Science. 69(5). 625–630. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Annick Massart Breakdown of academic impact, for papers by D Dahmane Breakdown of academic impact, for papers by B. Klare Breakdown of academic impact, for papers by K. V. Dakshinamurty Breakdown of academic impact, for papers by Elen Almeida Romão Breakdown of academic impact, for papers by Rosalía Valero Breakdown of academic impact, for papers by Philippe Eckart Breakdown of academic impact, for papers by Donald A. Leeber Breakdown of academic impact, for papers by Magdalena Salcedo Breakdown of academic impact, for papers by Brian Gallay
Rankless by CCL
2026